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Abstract
Despite the documented clinical efficacy, the injection of subcutaneous heparin can be associated with adverse drug
reactions including bruising at the injection site. This study sought to systematically assess current evidence regarding the
effect of cold application as a fundamental nursing intervention on the occurrence and size of bruising at the injection site in
patients receiving subcutaneous heparin. A systematic review and meta-analysis of randomized controlled trials and quasi-
experimental studies was performed. Web of Knowledge, PubMed (including MEDLINE), Scopus, Embase, Cochrane library,
gray literature, and cross-referencing from reference lists were searched from 2000 to 2019. Quality of selected studies was
assessed using the Cochrane risk of bias appraisal tool for randomized controlled trials and the JBI MASTARI appraisal tool
for quasi-experimental studies. The search yielded 3,220 articles, but consideration of inclusion criteria led to final selection
of 9 articles. The meta-analysis showed that cold application significantly reduced the relative occurrence of bruising at the
subcutaneous heparin injection site by 40% (relative risk, 0.60; 95% confidence interval [0.39, 0.91]) and reduced the bruising
size (standardized mean difference, 2.78; 95% confidence interval [4.34, 1.22]). Cold application as a fundamental
nursing intervention can be an effective intervention to prevent adverse drug reactions at the injection site in terms of the
occurrence and size of bruising in patients receiving subcutaneous heparin.
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Introduction
The safe prescription and administration of medicines is
an essential part of safe nursing care (Lehne, 2013).
The administration of some medicines, especially subcu-
taneous injections, poses greater responsibilities on clin-
ical nurses to assess related adverse drug reactions
(ADRs) and the quality and safety of medication process
(Hunter, 2008). ADR is a noxious and unintended
response to a drug, which can occur at doses normally
used for therapeutic purposes (International Conference
on Harmonisation, 1996).
Subcutaneous heparin is administered extensively to
patients who need anticoagulant medicines to reduce
the harmful clot formation during hospitalization
(Ansell et al., 2008). It can create a more predictable
anticoagulant effect, increase bioavailability from the
subcutaneous site of injection, and has less frequent
dosing requirements. Also, its simple subcutaneous
administration permits short- and long-term prescrip-
tions (Katzung, Masters, & Trevor, 2012). However,
similar to other medicine, the use of subcutaneous
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heparin has its own side effects and ADRs including
pain at the injection site, local irritation, skin
lesions, and bruising (Karch, 2012; Kuzu & Ucar,
2001; Potter & Perry, 2008; Schindewolf et al., 2009).
They can result in patients’ anxiety, rejection of treat-
ment, and distrust in nurses’ competency for medicines
management (Chan, 2001; Klingman, 2000).
Cold application have various therapeutic benefits
and can relieve injection-related complications of subcu-
taneous heparin (Kozier, Erb, Berman, Snyder, &
Frandsen, 2016; Ross & Soltes, 1995). Bruising has
been reported as one of the most frequently observed
ADRs and side effects of subcutaneous heparin injec-
tion. For example, it is estimated that 26% to 90% of
low-molecular-weight heparin injections cause bruising
at the injection site (de Campos, da Silva, Beck, Secoli,
& de Melo Lima, 2013). Therefore, the effect of cold
application as a fundamental nursing intervention on
such a complication is of great importance for improving
the quality and safety of clinical practice. Studies on
appropriate nursing strategies for reducing bruising
associated with subcutaneous heparin injections can
improve the quality of nursing care and decrease
patients’ stress with the medication process
(Morissette, 2015). Previous clinical trials in nursing
(Amaniyan, Varaei, Vaismoradi, Haghani, & Sieloff,
2016; Avs¸ar & Kas¸ikc¸i, 2013; Sendir, Bu¨yu¨kyilmaz,
C¸elik, & Task€opru¨, 2015) have demonstrated the efficacy
of cold application to reduce the occurrence of bruising
at the injection site. However, some studies have
reported controversial results (Kuzu & Ucar, 2001;
Ross & Soltes, 1995). Given variations in the studies’
results, making a consistent conclusion on the efficacy
and direction of causality between cold application and
reduction of bruising at the injection site of subcutane-
ous heparin becomes difficult. Therefore, this study
aimed to (a) systematically review the randomized con-
trolled trials (RCTs) and quasi-experimental studies on
cold application and the occurrence and bruising size of
subcutaneous heparin at the injection site and (b) to
carry out a meta-analysis to evaluate whether the evi-
dence supports the effectiveness of cold application as a
conservative and fundamental nursing intervention for
the reduction of bruising at the injection site.
Methods
Study Design
This was a systematic review and meta-analysis of RCTs
and quasi-experimental studies comparing the applica-
tion of cold to the injection site versus no application
of cold on bruising in patients receiving subcutaneous
heparin. We adopted the Preferred Reporting Items
for Systematic Reviews (PRISMA) and Meta-Analyses
statements as the equator to carry out this review
(Moher, Liberati, Tetzlaff, Altman, & PRISMA
Group, 2009).
Search Strategy
Online platforms and databases of Web of Knowledge,
PubMed (including MEDLINE), Scopus, Embase, and
Cochrane library were searched for all relevant studies
published from January 2000 to March 2019, using the
Boolean search strategy (Table 1). Also, gray literature
and cross-referencing from the bibliographies of includ-
ed studies were searched to extend the search coverage.
Eligibility Criteria
According to the PICOS framework which considers the
characteristics of Participants, Intervention, Comparison,
Outcomes, and Study design, those studies that met
the following criteria were selected for data analysis:
(a) RCTs or quasi-experimental designs (allocation
of patients into different groups that was not truly
random such as allocation by the clinical setting), (b)
patients were administered the subcutaneous heparin
injection, (c) application of cold to the injection site,
(d) control group received the no cold application inter-
vention, and (e) description of ADRs as the primary
outcome in terms of the occurrence and size of bruising.
Studies published in languages other than English or
Farsi were excluded.
Data Extraction
Two of the authors (S. A. and A. G.) independently
screened each retrieved study as definitely or potentially
meeting the inclusion criteria and obviously not meeting
the inclusion criteria. Also, they read the full text of
articles in terms of definitely or potentially meeting
the criteria for eligibility. A pre-piloted data extraction
table was used to extract the studies’ data regarding the
author’s name, year of publication, country, type of
trial, sample size, age range of subjects, type of subcu-
taneous heparin injection, cold application, and
Table 1. Search Strategy of This Review.
1. “Heparin” OR “subcutaneous heparin” OR “Low Molecular
Weight” OR “Enoxaparin” OR “Dalteparin” OR “Factor Xa
Inhibitors” OR “Anticoagulants”
2. “Cryotherapy” OR “Cold compression” OR “Cold therapy”
OR “Cold application” OR “Ice”
3. “Ecchymosis” OR “Bruising” OR “Hematoma”
4. 1 AND 2 AND 3
5. “Clinical trial” OR “Randomized control trial” OR
“Quasi-randomized controlled trial” OR
“Quasi-experimental study”
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examined outcomes. Disagreements between the authors
were resolved through discussions and consultation with
a third author (M. V.). The details of the selection pro-
cess are displayed in Figure 1.
Risk of Bias Assessment
The Cochrane risk of bias appraisal tool was used
to assess the quality of RCTs. It addressed six specific
methodological domains, and each domain was rated as
unclear bias risk, low bias risk, and high bias risk (Higgins
et al., 2011). Furthermore, the JBI MASTARI appraisal
tool for experimental studies was used for the appraisal
of quasi-experimental studies (Joanna Briggs Institute,
2006). Quality assessment was conducted independently
by two authors (S. A. and A. G.), and potential disagree-
ments were resolved through discussions and consulta-
tion with a third person (M. V.).
Statistical Analysis
For the meta-analysis of ADRs in terms of the occur-
rence and size of bruising at the subcutaneous heparin
injection site, the relative risk (RR) and standardized
mean difference (SMD) along with 95% confidence
intervals (CIs) were calculated for each study. The
fixed-effects model or the random-effect model in case
of heterogeneity was used to conduct pooled analyses.
Subgroup analysis was conducted based on the study
design. Homogeneity was examined using the
DerSimonian and Laird method (DerSimonian &
Laird, 1986). The I2 statistic was used to evaluate het-
erogeneity among selected studies. Although there can
be no absolute rule for when heterogeneity becomes
important, the Cochrane Handbook for Systematic
Reviews of Interventions (Higgins & Green, 2011) ten-
tatively suggests that the adjective of substantial hetero-
geneity for I2 values ranges from 50% to 90%.
Records identified through search 
in databases (n= 3763) 
Sc
re
en
in
g
In
cl
ud
ed
 
El
ig
ib
ili
ty
Id
en
tif
ic
a
tio
n Additional records identified through 
other sources  
(n= 48) 
Deleting duplicates and titles (n= 3628) 
Records for abstracts 
reading  
(n= 183)  
Records excluded  
(n= 158)  
Full-text articles 
excluded,  
(n= 16): 
٭Unrelated intervention  
(8) 
٭Not randomized/quasi-
randomized (3) 
٭Unrelated outcomes 
(5)  Studies included in 
meta-analysis 
(n= 9) 
Full-text articles 
assessed for eligibility  
(n= 25) 
Figure 1. The selection process according to the PRISMA flow diagram.
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Therefore, heterogeneity was assumed when I2 was over
50%. For all cases, forest plots were drawn. The forest
plot summarized information on individual studies and
the observed effects of the intervention along with the
overall result. Also, if standard deviation was reported
zero, it was considered 0.5 for further analysis (Higgins
& Green, 2011; Li et al., 2016). When the analyzing ratio
was measured in the binary variable of bruising inci-
dence, the log ratio with its standard error was used as
inputs to the analysis (Harris et al., 2008). Threshold for
statistical significance was set at 0.05. All statistical anal-
yses were performed using the STATA software (version
14 MP).
Results
The search strategy led to the identification of 3,811
articles, of which 3,786 articles were duplicated or did
not meet the inclusion criteria and hence resulted in the
selection of 25 articles. After full-text appraisal, nine
articles remained: five were RCTs and four were quasi-
experimental studies. The characteristics of all nine stud-
ies were summarized in Table 2.
Occurrence of Bruising at the Injection Site
Six studies (Amaniyan et al., 2016; Avs¸ar & Kas¸ikc¸i,
2013; El-Deen & Youssef, 2018; Kuzu & Ucar, 2001;
Sendir et al., 2015; Varghese, Walia, Sharma, & Kaur,
2006) consisting of four RCTs and two quasi-
experimental studies reported the occurrence of bruising
as the study outcome. Bruising was assessed at different
time intervals in different studies, including 12, 48, and
72 hours. Since the 48-hour measurement was reported
in all of the included studies, occurrence of bruising for
the 48-hour interval was analyzed. Bruising was identi-
fied by observing any discoloration of the injection site
such as pink, red, blue, purple, pale green, yellow, and
brown (El-Deen & Youssef, 2018).
Since no overall heterogeneity was observed in the
RCTs (p¼ .898, I2¼ 0.0%), a fixed-effects model was
employed. The subgroup analysis was conducted based
on different study designs. According to the pooled anal-
ysis of RCTs, the cold application intervention reduced
the occurrence of bruising at the injection site by 33%.
On the other hand, the two quasi-experimental studies
were highly heterogeneous (p¼ 0, I2> 90%). The meta-
analysis of the quasi-experimental studies demonstrated
that cold application had no statistically significant
effect on the occurrence of bruising. In general, cold
application was associated with a decreased risk of bruis-
ing at the injection site compared with the control group
(RR, 0.60; 95% CI [0.39, 0.91]; Figure 2).
Bruising Size
All of the included studies reported the bruising size as
the outcome. The bruising size was assessed using a
transparent millimeter ruler or film in mm2 (measures
in cm were converted to mm). As of the bruising occur-
rence outcome, 48-hour measurements were analyzed.
All studies reported the quantitative measure of the
bruising size, except the Varghese et al.’s study (2006).
This outcome was reported as a categorical variable.
Also, El-Deen and Youssef (2018) reported it in different
units and did not provide more data to be included in
the data analysis. Such heterogeneities reduced the com-
parability of the results of these two studies with other
trials. Therefore, only the description of their results was
provided.
The subgroup analysis was conducted due to different
study designs. Regarding four RCTs (Amaniyan et al.,
2016; Kuzu & Ucar, 2001; Sendir et al., 2015; Shijila
& Tresa, 2016), pooled results showed a statistically
significant effect of the intervention (SMD, 5.27;
95% CI [9.81, 1.63]). In addition, for three quasi-
experimental studies (Avs¸ar & Kas¸ikc¸i, 2013; Batra,
2014; Rupam, Sheoran, & Sharma, 2018), pooled results
demonstrated that the cold application group had a
smaller bruise size compared to the control group
(SMD, 1.12; 95% CI [1.72, 0.11]). Overall, the
pooled analyses of RCTs and quasi-experimental studies
revealed that the intervention group had a smaller bruis-
ing size compared with the control group (SMD, 2.78;
95% CI [4.64, 1.22]; Figure 3). Sensitivity analysis
for the type of cold application (pre- or postinjection)
was performed by excluding the two studies, in which
cold application was administered before the injections
(Avs¸ar & Kas¸ikc¸i, 2013; Batra, 2014). The sensitivity
analyses still supported the effectiveness of the interven-
tion (SMD, 2.02; 95% CI [3.36, 0.18]). Varghese
et al. (2006) concluded that the use of moist ice pack
resulted in a significant lower bruise size compared to
the control group. El-Deen and Youssef (2018) found
that the two intervention groups who received cold
application had a lower size of bruising than the control
group.
Risk of Bias
The results of the assessment of risk of bias in the
RCTs and quasi-experimental studies were reported in
Tables 3 and 4.
Random sequence generation. Among the five RCTs, only
one study (Kuzu & Ucar, 2001) lacked the description of
the random sequence generation. However, most of the
included quasi-experimental studies were unclear in
terms of the process of assignment to treatment groups
4 SAGE Open Nursing
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(Avs¸ar & Kas¸ikc¸i, 2013; Batra, 2014; Rupam et al.,
2018).
Allocation concealment. There were differences in the allo-
cation concealment between the studies. Five studies
(Amaniyan et al., 2016; El-Deen & Youssef, 2018;
Rupam et al., 2018; Shijila & Tresa, 2016; Varghese
et al., 2006) adequately described allocation concealment
from the allocators. Therefore, they were considered at a
low risk of bias. Four others did not describe it clearly
(Avs¸ar & Kas¸ikc¸i, 2013; Batra, 2014; Kuzu & Ucar,
2001; Sendir et al., 2015).
Blinding. Amaniyan et al. (2016) reported that the asses-
sor of the bruising size was blinded and had no infor-
mation about the patient’s group within the process of
study. However, none of the included studies explained
the blinding of patients. The reason could be the identity
of the intervention that hindered the blinding of patients.
Incomplete outcome data. Five studies (Amaniyan et al.,
2016; Avs¸ar & Kas¸ikc¸i, 2013; Batra, 2014; Kuzu &
Ucar, 2001; Varghese et al., 2006) presented a suitable
description of patients who withdrew from the studies.
They were regarded to be at a low risk of bias. In one
study (Sendir et al., 2015), 6.25% dropouts were found
with no explained intention-to-treat analysis. So, it
might lead to a high risk of bias.
Selective outcome reporting. All studies reported all
expected outcomes and were supposed to have a low
risk of bias.
Other sources of bias. Some characteristics of the injec-
tions of subcutaneous heparin such as needle gage and
air lock were not described in the included studies, which
could influence their outcomes.
Publication Bias Assessment
To assess the funnel plot asymmetry test, at least 10
studies should be included in the review (Higgins &
Green, 2011; Mohammady, Janani, & Sari, 2017).
Since the number of included studies in this meta-
analysis violated this assumption, it was impossible to
prepare a funnel plot.
Discussion
The subcutaneous injection of heparin is a common and
fundamental clinical intervention in various healthcare
settings performed by clinical nurses. However, it is
accompanied with a number of ADRs and side effects,
of which bruising at the injection site is more frequent
(de Campos et al., 2013). To minimize it, it is incumbent
to nurses to investigate the potentially effective interven-
tions such as cold application to reduce it as much as
possible and improve the quality and safety of patient
care. Noninvasive and safe strategies that can result in
less and smaller bruising at the injection site of subcuta-
neous heparin should be suggested by nurses to promote
the safety of medicines management and prevent non-
adherence to the therapeutic regime.
Summarizing Main Findings
To our knowledge, this is the first meta-analysis on the
effectiveness of cold application on bruising at the sub-
cutaneous heparin injection site. To control the proba-
bility of missing relevant data, a comprehensive search
was performed to detect and retrieve articles and to
evaluate the selected studies in terms of methodology
and risk of bias. Due to a lack of sufficient numbers of
RCTs on the study phenomenon, the authors broadened
inclusion criteria and included quasi-experimental
studies to this review. All studies reported the expected
outcome and had a relatively low risk of bias. However,
the majority of them did not report anything about the
characteristics of injection of subcutaneous heparin.
Therefore, it could affect on the statistical power of anal-
ysis. Overall, the significant effects of the cold applica-
tion intervention on the reduction of occurrence and size
of bruising at the subcutaneous heparin injection site
after 48-hour follow-up compared to the control group
were reported.
Mechanism
The mechanism of why cold application can reduce
the bruising occurrence and its size is attributed to vaso-
constriction (Kuzu & Ucar, 2001; Lynn, 2018). Cold
application at the subcutaneous injection site can control
bleeding through arterioles’ vasoconstriction, decrease
blood flow to the affected site, and control the develop-
ment of bruising through the reduction of
capillary permeability and metabolic needs (Kilic &
Midilli, 2008).
Previous Meta-Analysis of Bruising at the
Subcutaneous Heparin Injection Site
Yi et al. (2016) pooled the results of five RCTs and three
quasi-experimental studies, investigating the effect of the
duration of subcutaneous injection on patients receiving
low-molecular-weight heparin. They found that slow
injection technique would be beneficial to the patients
in terms of both the occurrence and size of bruising com-
pared to the fast injection techniques.
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Limitations of This Study
The limitations of this meta-analysis should be consid-
ered during the interpretation of findings. The presence
of more RCTs could afford the researchers to provide a
more in-depth insight into the study topic. Due to the
nature of meta-analysis, the use of aggregated group
data for calculating the effect size can ignore the effect
of other potential confounding factors influencing the
outcomes of interest. In addition, the heterogeneity
Figure 3. Meta-analysis for the bruising size in the RCTs (based on the random effect model) and the quasi-experimental studies (based
on the fixed-effect model). RCT¼randomized controlled trial; SD¼ standard deviation; SMD¼ standardized mean difference;
CI¼ confidence interval.
Figure 2. Meta-analysis of the bruising incidence in the RCTs (based on the fixed effect model) and the quasi-experimental studies (based
on the random-effect model). RCT¼randomized controlled trial; RR¼ relative risk; CI¼ confidence interval.
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in the duration of cryotherapy applied in the included
studies could have some effects on the study outcomes.
Cold application is recommended only for 5 to
10minutes in terms of effectiveness, but cooling is con-
sidered enough (Ward, 2000).
Implications for Practice
This study provides knowledge about the prevention
of bruising associated with the subcutaneous heparin
injection. Accordingly, clinical nurses are suggested
to use cold packs to reduce the occurrence and size of
bruising associated with subcutaneous heparin injection.
Implementation of this nursing intervention is inexpen-
sive, easy to administer, and readily acceptable to
patients in various health conditions even at home.
Nevertheless, during the application of cold, efforts by
nurses are needed to assess the patient’s response, pre-
serve his or her privacy, and prevent possible negative
consequences of cold application on the skin. Further
studies are required to understand the effectiveness of
cold application and cryotherapy on other health-
related indicators including pain and psychological
indicators.
Conclusion
According to this study, cold application can reduce
ADRs in terms of the occurrence of bruising and its
size at the subcutaneous heparin injection site.
Table 4. Risk of Bias in the Quasi-Experimental Studies.
Study Q1 Q2 Q3 Q4 Q5 Q6 Q7 Q8 Q9 Q10
Ruamp et al. (2018)
El-Deen and Youssef (2018)
Batra (2014)
Avsar and Kasikc¸i (2013)
¼ low risk of bias; ¼ high risk of bias; ¼ unclear risk of bias.
Q1: Was the assignment to treatment groups truly random?; Q2: Were participants blinded to treatment allocation?; Q3: Was allocation to treatment
groups concealed from the allocator?; Q4: Were the outcomes of people who withdrew described and included in the analysis?; Q5: Were those assessing
the outcomes blind to the treatment allocation?; Q6: Were control and treatment groups comparable?; Q7: Were groups treated identically other than for
the named intervention?; Q8: Were outcomes measured in the same way for all groups?; Q9: Were outcomes measured in a reliable way?; Q10: Was
appropriate statistical analysis used?
Table 3. Risk of Bias in the Randomized Control Trials.
Random
sequence
generation
Allocation
concealment Blinding
Incomplete
outcome data
Selective
outcome
reporting
Other
sources
of bias
Amaniyan et al. (2016)
Shijila and Tresa (2016)
Sendir et al. (2015)
Varghese et al. (2006)
Kuzu and Ucar (2001)
¼ low risk of bias; ¼ high risk of bias; ¼ unclear risk of bias.
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Therefore, cold application as a safe and fundamental
nursing intervention can be used along with other caring
modalities to reduce the side effects of the subcutaneous
heparin administration such as bruising and hematoma.
More studies are required to investigate the effects of
fundamental nursing interventions on the reduction of
medicines’ side effects and ADRs in line with the nurses’
role and involvement in medicine management initiatives
and patient safety.
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